Intracellular delivery: Exploiting viral membranotropic peptides

Current Drug Metabolism

Volumn 13, Issue 1, 2012, Pages 93-104

  Galdiero, Stefania ^a,b   Vitiello, Mariateresa ^a   Falanga, Annarita ^a   Cantisani, Marco ^a   Incoronato, Novella ^a   Galdiero, Massimiliano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

Cell penetrating peptides; Endocytosis; Intracellular delivery; Membrane fusion; Viral fusion proteins

Indexed keywords

ALAMETHICIN; ARGININE; CELL PENETRATING PEPTIDE; CLATHRIN; COAT PROTEIN; COAT PROTEIN GAMMA PEPTIDE; DRUG VEHICLE; GALANIN; GH625 PROTEIN; GLYCOPROTEIN; GLYCOPROTEIN GP 41; HEPATITIS B SURFACE ANTIGEN; LYSINE; MASTOPARAN; MELITTIN; MEMBRANE PROTEIN; MODEL AMPHIPATHIC PEPTIDE; PENETRATIN; PEP 1 PROTEIN; POLYARGININE; POLYPEPTIDE ANTIBIOTIC AGENT; PRES2 PROTEIN; PROTEIN VP22; SYNTHETIC PEPTIDE; TRANSACTIVATOR PROTEIN; TRANSPORTAN; TRYPTOPHAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS FUSION PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CYTOPLASM; DRUG DELIVERY SYSTEM; DRUG STABILITY; ENDOCYTOSIS; HEPATITIS B VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHILICITY; HYDROPHOBICITY; IMMUNOGENICITY; INTERNALIZATION; NODAVIRUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; THERMODYNAMICS; VIRUS; VIRUS CAPSID; VIRUS ENVELOPE; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN;

EID: 84857613440     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920012798356961     Document Type: Review

References (124)

1. Räty, J.K.; Lesch, H.P.; Wirth, T.; Ylä-Herttuala, S. Improving safety of gene therapy. Curr. Drug Saf., 2008, 3(1), 46-53. (Pubitemid 351223153)
2. Duan, Y.; Zhang, S.; Wang, B.; Yang, B.; Zhi, D. The biological routes of gene delivery mediated by lipid-based non-viral vectors. Expert Opin. Drug Deliv., 2009, 6, 1351-1361.
3. Ditto, A.J.; Shah, P.N.; Yun, Y.H. Non-viral gene delivery using nanoparticles. Expert Opin. Drug Deliv., 2009, 6, 1149-60.
4. Pathak A.; Patnaik S.; Gupta KC. Recent trends in non-viral vectormediated gene delivery. Biotechnol. J. 2009, 4, 1559-1572.
5. Langel; Ü. in: Ü. Langel (Ed.). Cell-Penetrating Peptides: Processes and Applications; CRC Press; Boca Raton; 2002.
6. Langel; Ü. in: U. Langel (Ed.). Handbook of Cell-Penetrating Peptides; CRC Taylor & Francis; Boca Raton; 2007.
7. Heitz; F.; M.C. Morris.; G. Divita.; Twenty years of cellpenetrating peptides: From molecular mechanisms to therapeutics. Br. J. Pharmacol. 2009, 157, 195-206.
8. Deshayes, S.; M.C. Morris.; F. Heitz.; G. Divita. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv. Drug Deliv. Rev. 2008; 60, 537-547. (Pubitemid 351222678)
9. Deshayes, S.; Morris, M.C.; Divita, G.; Heitz, F. Cell-penetrating peptides: Tools for intracellular delivery of therapeutics. Cell. Mol. Life Sci. 2005, 62,1839-1849. (Pubitemid 41188523)
10. Snyder, E.L.; S.F. Dowdy. Recent advances in the use of protein transduction domains for the delivery of peptides; proteins and nucleic acids in vivo. Expert Opin. Drug Deliv., 2005, 2,43-51. (Pubitemid 40123882)
11. Eguchi, A.; S.F. Dowdy. siRNA delivery using peptide transduction domains. Trends Pharmacol. Sci., 2009, 30, 341-345.
12. Frankel, A.D.; C.O. Pabo. Cellular uptake of the tat protein from human immunodeficiency virus. Cell, 1988, 55,1189-1193. (Pubitemid 19020071)
13. Joliot, A.; C. Pernelle.; H. Deagostini-Bazin.; A. Prochiantz. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. USA, 1991, 88,1864-1868. (Pubitemid 21916327)
14. Derossi, D.; A.H. Joliot.; G. Chassaing.; A. Prochiantz. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994, 269, 10444-10450. (Pubitemid 24198241)
15. Vives, E.; P. Brodin.; B. Lebleu. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem., 1997, 272,16010-16017. (Pubitemid 27265584)
16. Schwarze, S.R.; A. Ho.; A. Vocero-Akbani.; S.F. Dowdy; In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science, 1999, 285,1569-1572. (Pubitemid 29420581)
17. Pooga, M.; Hällbrink, M.; Zorko, M.; Langel, U. Cell penetration by transportan. FASEB J., 1998,12, 67-77. (Pubitemid 28060272)
18. Elliott, G.; P. O'Hare. Intercellular trafficking and protein delivery by a Herpesvirus structural protein. Cell, 1997, 88, 223-233. (Pubitemid 28015871)
19. Oess, S.; Hildt, E. Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens. Gene Ther., 2000, 7, 750-758. (Pubitemid 30255756)
20. Rennert, R.; I. Neudorf.; A. Beck-Sickinger. Calcitoinin-derived peptide carriers: Mechanisms and application. Adv. Drug Deliv. Rev., 2008, 60, 485-499.
21. Järver, P.; Langel, K.; El-Andaloussi, S.; Langel U. Applications of cell-penetrating peptides in regulation of gene expression. Biochem. Soc. Trans., 2007, 35, 770-774. (Pubitemid 47310365)
22. Ter-Avetisyan, G.; Tünnemann, G.; Nowak, D.; Nitschke, M.; Herrmann, A.; Drab, M.; Cardoso, M.C. Cell entry of arginine-rich peptides is independent of endocytosis. J. Biol. Chem., 2009, 284, 3370-3378.
23. Stewart, K.M.; K.L. Horton.; S.O. Kelley. Cell-penetrating peptides as delivery vehicles for biology and medicine. Org. Biomol. Chem., 2008, 6, 2242-2255. (Pubitemid 351863664)
24. Vives, E. J. Schmidt.; A. Pelegrin. Cell-penetrating and celltargeting peptides in drug delivery. Biochim. Biophys. Acta, 2008, 1786,126-138.
25. Dietz, G.P.; M. Bahr. Delivery of bioactive molecules into the cell: The Trojan horse approach. Mol. Cell. Neurosci., 2004, 27,85-131. (Pubitemid 39370094)
26. Schwarze, S.R.; K.A. Hruska.; S.F. Dowdy.; Protein transduction: Unrestricted delivery into all cells? Trends Cell Biol., 2000, 10, 290-295. (Pubitemid 30387038)
27. Fonseca, S.B.; Pereira, M.P.; Kelley, S.O. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv. Drug Deliv. Rev., 2009, 30, 61(11), 953-964.
28. Morris, M.C.; Deshayes, S.; Heitz, F.; Divita, G. Cell-penetrating peptides: From molecular mechanism to therapeutics. Biol. Cell, 2008, 100, 201-217. (Pubitemid 351517084)
29. Sawant, R.; Torchilin, V. Intracellular transduction using cellpenetrating peptides. Mol. Biosyst., 2009, 6, 628-640.
30. Loret, E. P.; Vives, E.; Ho, P. S.; Rochat, H.; Van Rietschoten, J.; Johnson Jr, W. C. Activating region of HIV-1 Tat protein: Vacuum UV circular dichroism and energy minimization. Biochem., 1991, 30, 6013-6023.
31. Bloch-Gallego, E.; Le Roux, I.; Joliot, A.H.; Volovitch, M.; Henderson, C.E.; Prochiantz, A. Antennapedia homeobox peptide enhances growth and branching of embryonic chicken motoneurons in vitro. J. Cell Biol., 1993, 120(2), 485-492. (Pubitemid 23040086)
32. Gehring, W.J.; Affolter, M.; Bürglin T. Homeodomain proteins. Annu Rev Biochem. 1994;63:487-526. (Pubitemid 24218641)
33. Bellet-Amalric E.; Blaudez D.; Desbat B.; Graner F.; Gauthier F. and Renault A. Interaction of the third helix of Antennapedia homeodomain and a phospholipid monolayer; studied by ellipsometry and PM-IRRAS at the air-water interface. Biochim. Biophys. Acta, 2000, 1467, 131-143. (Pubitemid 30621592)
34. Magzoub, M.; Kilk, K.; Eriksson, L. E.; Langel, U. Graslund, A. Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles. Biochim. Biophys. Acta, 2001, 1512, 77-89. (Pubitemid 32378784)
35. Magzoub, M.; Eriksson, L. E.; Graslund A. Conformational states of the cell-penetrating peptide penetratin when interacting with phospholipid vesicles: Effects of surface charge and peptide concentration. Biochim. Biophys. Acta., 2002, 1563, 53-63. (Pubitemid 34455043)
36. Lindgren, M.; Gallet, X.; Soomets, U.; Hällbrink, M.; Brakenhielm, E.; Pooga, M.; Brasseur, R. Langel, Ü. Translocation properties of novel cell penetrating transportan and penetratin analogues. Bioconjug. Chem., 2000, 11,619-626.
37. Lindberg, M.; Jarvet, J.; Langel, U.; Gräslund, A. Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR. Biochem., 2001, 40, 3141-3149 (Pubitemid 32205358)
38. Bárány-Wallje, E.; Andersson, A.; Gräslund, A.; Mäler, L. NMR solution structure and position of transportan in neutral phospholipid bicelles. FEBS Lett., 2004, 567, 265-269. (Pubitemid 38748403)
39. Steiner, V.; Schar, M.; Bornsen, K.O.; Mutter, M. Retention behaviour of a template-assembled synthetic protein and its amphiphilic building blocks on reversed-phase columns. J. Chromatogr., 1991,586,43-50.
40. Oehlke, J.; Scheller, A.; Wiesner, B.; Krause, E.; Beyermann, M.; Klauschenz, E.; Melzig, M.; Bienert, M. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta, 1998,1414, 127-139. (Pubitemid 28511045)
41. Morris, M.C.; Vidal, P.; Chaloin, L.; Heitz, F. Divita; G. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res., 1997, 25, 2730-2736. (Pubitemid 27299785)
42. Morris, M.C.; Chaloin, L.; Méry, J.; Heitz, F. Divita, G. A novel potent strategy for gene delivery using a single peptide vector as a carrier. Nucleic Acids Res., 1999, 27,3510-3517. (Pubitemid 29414679)
43. Gallaher; W.R. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell, 1987, 50,327-328.
44. Freed, E.O.; Myers, D.J. Risser, R. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.Proc. Natl. Acad. Sci. USA, 1990, 87, 4650-4654.
45. Delahunty, M.D.; Rhee, I.; Freed, E.O.; Bonifacino, J.S. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: Identification of critical glycine residues. Virology, 1996, 218, 94-102. (Pubitemid 26133090)
46. Kalderon, D.; Richardson, W.D.; Markham, A.F. Smith, A.E. In vitro mutagenesis of a putative DNA binding domain of SV40 large-T. Nature, 1984,311, 33-38.
47. Dingwall, C.; Laskey, R. The nuclear membrane. Science, 1992, 258, 942-947.
48. Morris, M. C.; Depollier, J.; Mery, J.; Heitz, F.; Divita, G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol., 2001,19, 1173-1176. (Pubitemid 33115705)
49. Deshayes, S.; Gerbal-Chaloin, S.; Morris, M.C.; Aldrian-Herrada, G.; Charnet, P.; Divita, G.; Heitz, F. On the mechanism of nonendosomial peptide-mediated cellular delivery of nucleic acids. Biochim. Biophys. Acta. 2004, 15, 1667(2),141-147. (Pubitemid 39576077)
50. Futaki, S.; T. Suzuki.; W. Ohashi.; T. Yagami.; S. Tanaka.; K. Ueda. Arginine-rich peptides: An abundant source of membranepermeable peptides having potential as carriers for intracellular protein delivery; J. Biol. Chem., 2001, 276, 5836-5840.
51. Elliott; G. D.; and D. M. Meredith. The herpes simplex virus type 1 tegument protein VP22 is encoded by gene UL49. J. Gen. Virol. 1992;73:723-726.
52. Sciortino, M.T.; Suzuki, M.; Taddeo, B.; Roizman, B. RNAs extracted from herpes simplex virus 1 virions: Apparent selectivity of viral but not cellular RNAs packaged in virions. J. Virol.; 2001,75, 8105-8116. (Pubitemid 32743683)
53. Normand, N.; van Leeuwen, H.; O'Hare, P. Particle formation by a conserved domain of the herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery. J. Biol. Chem., 2001, 276, 15042-15050.
54. Sciortino, M. T.; Taddeo, B.; Poon, A. P. W.; Mastino, A.; Roizman, B. Of the three tegument proteins that package mRNA in herpes simplex virions; one (VP22) transports the mRNA to uninfected cells for expression prior to viral infection. Proc. Natl. Acad. Sci. USA., 2002, 99, 8318-8323. (Pubitemid 34651050)
55. Hildt, E.; Urban, S.; Hofschneider, P.H. Characterization of essential domains for the functionality of the MHBst transcriptional activator and identification of a minimal MHBst transactivator. Oncogene, 1995, 11, 2055-2066.
56. Banerjee, M.; J. E. Johnson. Activation; exposure and penetration of virally encoded; membrane-active polypeptides during nonenveloped virus entry. Curr. Protein Pept. Sci., 2008, 916-927.
57. Janshoff, A.; D. T. Bong.; C. Steinem.; J. E. Johnson.; M. R. Ghadiri. An animal virus-derived peptide switches membrane morphology: Possible relevance to nodaviral transfection processes. Biochem.,1999, 38,5328-5336.
58. Bong, D. T.; C. Steinem.; A. Janshoff.; J. E. Johnson.; M. R. Ghadiri. A highly membrane active peptide in Flock House Virus: Implications for the mechanism of nodavirus infection. Chem. Biol., 1999,6,473-481. (Pubitemid 29311484)
59. Bong, D.T.; Janshoff, A.; Steinem, C.; Ghadiri M.R. Membrane Partitioning of the Cleavage Peptide in Flock House Virus. Bioph. J., 2000, 78, 839-845. (Pubitemid 30211841)
60. Nakase, I.; Hirose, H.; Tanaka, G.; Tadokoro, A.; Kobayashi, S.; Takeuchi, T.; Futaki, S. Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis. Mol. Ther., 2009, 17,1868-1876.
61. Galdiero, S.; A. Falanga.; M. Vitiello.; L. Raiola.; L. Russo.; C. Pedone.; C.Isernia.; M. Galdiero. "The presence of a single Nterminal histidine residue enhances the fusogenic properties of a membranotropic peptide derived from herpes simplex virus type 1 glycoprotein H. J. Biol. Chem, 2010, 285(22), 17123-17136.
62. Falanga; M. Vitiello; M. Cantisani; R. Tarallo; D. Guarnieri; E. Mignogna; P. Netti; C. Pedone; M. Galdiero; S. Galdiero. A peptide derived from Herpes Simplex Virus type 1 glycoprotein H: Membrane translocation and applications to the delivery of quantum dots. Nanomedicine; 2011, doi:10.1016/j.n.nano.2011.04.009.
63. Bais, M.V.; Kumar, S.; Tiwari, A.K.; Kataria, R.S.; Nagaleekar, V.K.; Shrivastava, S.; Chindera, K. Novel Rath peptide for intracellular delivery of protein and nucleic acids. Biochem. Biophys. Res. Commun., 2008, 370, 27-32.
64. Plank, C.; Zauner, W.; Wagner, E.; Application of membraneactive peptides for drug and gene delivery across cellular membranes. Adv. Drug Deliv. Rev., 1998, 34, 21-35. (Pubitemid 28464476)
65. Harrison, S.C. Viral membrane fusion. Nat. Struct. Mol. Biol., 2008,15(7), 690-698. (Pubitemid 351932011)
66. White, J.M.; Delos, S.E.; Brecher, M.; Schornberg, K. Structures and mechanisms of viral membrane fusion proteins: Multiple varia tions on a common theme. Crit. Rev. Biochem. Mol. Biol., 2008, 43(3),189-219. (Pubitemid 351883153)
67. Tsai, B.; Penetration of non-enveloped viruses into the cytoplasm. Annu. Rev. Cell Dev. Biol., 2007, 23,23-43.
68. Zlotnick, A.; Reddy, V.S.; Dasgupta, R.; Schneemann, A.; Ray, W.J. Jr.; Rueckert, R.R.; Johnson, J.E. Capsid assembly in a family of animal viruses primes an autoproteolytic maturation that depends on a single aspartic acid residue. J. Biol. Chem., 1994, 6,269(18):13680-13684. (Pubitemid 24206149)
69. Arnold, E.; Luo, M.; Vriend, G.; Rossmann, M. G.; Palmenberg, A. C.; Parks, G. D.; Nicklin, M. J.; Wimmer,; E. Implications of the picornavirus capsid structure for polyprotein processing. Proc. Natl. Acad. Sci. U.S.A. 1987,84,21-25. (Pubitemid 17013570)
70. Ivanovic, T.; Agosto, M. A.; Zhang, L.; Chandran, K.; Harrison, S. C.; Nibert, M. L. Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. EMBO. J., 2008, 27,1289-1298. (Pubitemid 351574754)
71. Arias, C. F.; Romero, P.; Alvarez, V.; Lopez, S. Trypsin activation pathway of rotavirus infectivity. J. Virol., 1996,70, 5832-5839. (Pubitemid 26266793)
72. Greber, U. F.; Webster, P.; Weber, J.; Helenius, A. The role of the adenovirus protease on virus entry into cells. EMBO. J., 1996,15,1766-1777. (Pubitemid 26119212)
73. Da Costa, B.; Chevalier, C.; Henry, C.; Huet, J. C.; Petit, S.; Lepault, J.; Boot, H.; Delmas, B. The capsid of infectious bursal disease virus contains several small peptides arising from the maturation process of pVP2. J. Virol., 2002, 76, 2393-2402. (Pubitemid 34150707)
74. Galloux, M.; Libersou,; S.; Alves,I. D.; Marquant, R.; Salgado, G. F.; Rezaei, H.; Lepault, J.; Delmas, B.; Bouaziz, S.; Morellet, N. NMR Structure of a Viral Peptide Inserted in Artificial Membranes "A VIEW ON THE EARLY STEPS OF THE BIRNAVIRUS ENTRY PROCESS" ; J. Biol. Chem., 2010,285, 25,19409-19421.
75. Harrison, S.C. Mechanism of membrane fusion by viral envelope proteins. Adv. Virus. Res.; 2005, 64,231-261. (Pubitemid 43574760)
76. Lamb, R.A.; Paterson, R.G.; Jardetzky, T.S. Paramyxovirus membrane fusion: Lessons from the F and HN atomic structures. Virology, 2006, 344(1), 30-37. (Pubitemid 41814447)
77. Stiasny, K.; Heinz, F.X. Flavivirus membrane fusion. J. Gen. Virol., 2006,87(10),2755-2766. (Pubitemid 44463884)
78. Kielian, M. Class II virus membrane fusion proteins. Virology, 2006, 344(1),38-47. (Pubitemid 41814448)
79. Kielian, M.; Rey, F.A. Virus membrane-fusion proteins: More than one way to make a hairpin. Nat. Rev. Microbiol., 2006, 4(1),67-76. (Pubitemid 43135288)
80. Weissenhorn, W.; Hinz, A.; Gaudin, Y. Virus membrane fusion. FEBS Lett., 2007,581(11),2150-2155. (Pubitemid 46722604)
81. Backovic, M. Jardetzky, T. S. Class III viral membrane fusion proteins. Curr. Opin. Struct. Biol., 2009,19,189-196.
82. Wilson, I.A.; Skehel, J.J.; Wiley, D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature, 1981, 289(5796), 366-373.
83. Fass, D.; Harrison, S.C.; Kim, P.S. Retrovirus envelope domain at 1.7 angstrom resolution Nat. Struct. Biol.; 1996, 3(5), 465-469.
84. Weissenhorn, W.; Carfi, A.; Lee, K.H.; Skehel, J.J.; Wiley, D.C. Crystal structure of the Ebola virus membrane fusion subunit; GP2; from the envelope glycoprotein ectodomain. Molecular. Cell.; 1998, 2(5), 605-616. (Pubitemid 128379086)
85. Xu, Y.; Liu, Y.; Lou, Z.; Qin, L.; Li, X.; Bai, Z.; Pang, H.; Tien, P.; Gao, G.F.; Rao, Z. Structural basis for coronavirus-mediated membrane fusion: Crystal structure of mouse hepatitis virus spike protein fusion core. J. Biol. Chem.; 2004, 279(29), 30514-30522. (Pubitemid 38937982)
86. Yin, H.S.; Wen, X.; Paterson, R.G.; Lamb, R.A.; Jardetzky, T.S. Structure of the parainfluenza virus 5 F protein in its metastable; prefusion conformation. Nature, 2006, 439 (7072), 38-44. (Pubitemid 43053622)
87. Schibli, D.J.; Weissenhorn, W. Class I and class II viral fusion protein structures reveal similar principles in membrane fusion. Mol. Membr. Biol., 2004, 21(6), 361-371. (Pubitemid 40030212)
88. Rey, F.A.; Heinz, F.X.; Mandl, C.; Kunz, C.; Harrison, S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature, 1995, 375(6529), 291-298.
89. Lescar, J.; Roussel, A.; Wien, M.W.; Navaza, J.; Fuller, S.D.; Wengler, G.; Wengler, G.; Rey, F.A. The Fusion glycoprotein shellof Semliki Forest virus: An icosahedral assembly primed for fusogenic activation at endosomal pH. Cell, 2001,105(1),137-148. (Pubitemid 32323923)
90. Modis, Y.; Ogata, S.; Clements, D.; Harrison, S.C. A ligandbinding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA, 2003, 100(12), 6986-6991. (Pubitemid 36706380)
91. Roche, S.; Bressanelli, S.; Rey, F.A.; Gaudin, Y. Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science, 2006, 313(5784),187-191. (Pubitemid 44066243)
92. Heldwein, E.E.; Lou, H.; Bender, F.C.; Cohen, G.H.; Eisenberg, R.J.; Harrison, S.C. Crystal structure of glycoprotein B from herpes simplex virus 1. Science, 2006, 313(5784),217-220. (Pubitemid 44066251)
93. Kadlec, J.; Loureiro, S.; Abrescia, N.G.; Stuart, D.I.; Jones, I.M. The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat. Struct. Mol. Biol.; 2008, 15(10), 1024-1030.
94. Backovic, M.; Longnecker, R.; Jardetzky, T.S.: Structure of a trimeric variant of the Epstein-Barr virus glycoprotein. B. Proc. Natl. Acad. Sci., U S A, 2009,106,2880-2885.
95. Scudiero, O.; S. Galdiero.; M. Cantisani.; R. Di Noto.; M. Galdiero.; M. D'Isanto.; G. Naclerio.; C. Pedone.; G. Castaldo.; F. Salvatore .Synthetic analogs of human beta-defensins display a more effective antimicrobial activity than wild-type peptides. Antimicrob. Agents Chemother., 2010, 54(6), 2312-2322 .
96. Galdiero, S.; M. Galdiero.; C. Pedone. β-barrel membrane bacterial proteins: Structure; function; assembly and interaction with lipids. Curr. Protein Pep. Sci., 2007, 8, 63-82. (Pubitemid 46322270)
97. Falanga, A.; Cantisani, M.; Pedone, C.; Galdiero, S. Membrane Fusion and Fission: Enveloped viruses. Protein Pep. Lett.; 2009, 16 (7), 751-759.
98. Galdiero, S. Developments In Membrane Fusion. Protein Pep. Lett., 2009, 16 (7),711.
99. Fominaya, J.; Wels, W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein-novel non-viral gene delivery system; J. Biol. Chem. 1996, 271,10560-10568. (Pubitemid 26145790)
100. Gottschalk, S.; Sparrow, J.T.; Hauer, J.; M.P. Mims, M.P.; Leland, F.E.; Woo, S.L.C.; Smith, L.C. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells; Gene Ther. 1996, 3, 448-457. (Pubitemid 26171343)
101. Greber, U.F.; Willetts, M.; Webster, P.; Helenius, A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell, 1993, 75, 477-486. (Pubitemid 23335073)
102. Leopold, P.L.; Ferris,B.; Grinberg, I.; Worgall, S.; Hackett, N.R.; Crystal, R.G. Fluorescent virions: Dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells; Hum. Gene Ther., 1998, 9, 367-378. (Pubitemid 28085024)
103. Langel U. Handbook of Cell Penetrating Peptides. CRC Press: Boca Raton; FL; 2006.
104. Joliot, A.; Prochiantz, A. Transduction peptides: From technology to physiology. Nat. Cell Biol., 2004, 6, 189-196. (Pubitemid 38344356)
105. Mae, M.; Langel, U. Cell-penetrating peptides as vectors for peptide; protein and oligonucleotide delivery. Curr. Opin. Pharmacol., 2006, 6,509-514. (Pubitemid 44340662)
106. Deshayes, S.; Heitz, A.; Morris, M.C.; Charnet, P.; Divita, G.; Heitz, F. Insight into the mechanism of internalization of the cellpenetrating carrier peptide Pep-1 through conformational analysis Biochem. 2004, 43, 1449-1457. (Pubitemid 38200550)
107. Deshayes, S.; Plenat, T.; Aldrian-Herrada, G.; Divita, G.; Le Grimellec, C.; Heitz, F.; Primary amphipathic cell-penetrating peptides: Structural requirements and interactions with model membranes Biochem. 2004, 43, 7698-7706. (Pubitemid 38787677)
108. Henriques, S.T.; Melo, M.N; Castanho, M. Cell-penetrating peptides and antimicrobial peptides: How different they are? Biochem. J., 2006, 399, 1-7. (Pubitemid 44505401)
109. Crombez, L.; Morris, M.C.; Dufort, S.; Aldrian-Herrada, G.; Nguyen, Q.; Mc Master, G.; Coll, J.L.; Heitz, F.; Divita, G. Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. Nucleic Acids Res., 2009, 37(14), 4559-4569.
110. Konate, K.; Crombez, L.; Deshayes, S.; Decaffmeyer, M.; Thomas, A.; Brasseur, R.; Aldrian, G.; Heitz, F.; Divita, G. Insight into the cellular uptake mechanism of a secondary amphipathic cellpenetrating peptide for siRNA delivery. Biochem., 2010, 49(16), 3393-3402.
111. Morris, M.C.; Depollier, J.; Mery, J.; Heitz, F.; Divita, G. A peptide carrier for the delivery of biologically active proteins into mammalian cells: Application to the delivery of antibodies and therapeutic proteins. In cell Biology: A Laboratory Handbook (Celis; J. E.; ed.) 2006, 4, 13-18.
112. Gallo, G. Making proteins into drugs: Assisted delivery of proteins and peptides into living neurons. Methods Cell Biol., 2003, 71, 325-338.
113. Henriques, S.T.; Castanho, M. ARB.; translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity. J. Pept. Sci., 2008, 14, 482-487. (Pubitemid 351540910)
114. El-Sayed, A.; Masuda, T.; Khalil, I.; Akita, H.; Harashima, H. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape. J.Control Release, 2009, 138(2), 160-167.
115. Neundorf, I.; Rennert, R.; Hoyer, J.; Schramm, F.; Lobner, K.; Kitanovic, I.; Wolfl, S. Fusion of a short HA2-derived peptide sequence to cell-penetrating peptides improves cytosolyc uptake; but enhances cytotoxic activity Pharmac., 2009, 2, 49-65.
116. Funhoff, A.M.; Van Nostrum, C.F.; Lok, M.C.; Fretz, M.M.; Crommelin, D.J.;. Hennink, W.E. Poly (3-guanidinopropyl methacrylate): A novel cationic polymer for gene delivery; Bioconjugate Chemistry, 2004, 15(6), 1212-1220. (Pubitemid 39552009)
117. Jiang, X.; Lok, M.C.; Hennink, W.E. Degradable-brushed pHEMA-pDMAEMA synthesized via ATRP and click chemistry for gene delivery; Bioconjugate Chemistry, 2007, 18 (6), 2077-2084. (Pubitemid 350220011)
118. Mastrobattista, E.; Koning, G.A.; Van Bloois, L.; Filipe, A.C.; Jiskoot, W.; Storm, G.; Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins; J. Biol. Chem. 2002, 277 (30), 27135-27143. (Pubitemid 34951728)
119. Fretz, M.M.; Mastrobattista, E., Koning, G.A.; Jiskoot, W.; Storm, G.; Strategies for cytosolic delivery of liposomal macromolecules; Int. J. Pharmac., 2005, 298 (2), 305-309. (Pubitemid 40910733)
120. Simeoni, F.; Morris, M. C.; Heitz, F.; Divita, G. Insight into the mechanism of the peptide-based gene delivery system MPG: Implications for delivery of siRNA into mammalian cells. Nucleic acids res., 2003, 31, 2717-2724. (Pubitemid 37442116)
121. Galdiero, S.; Falanga, A.; Vitiello, M.; Raiola, L.; Fattorusso, R.; Browne, H.; Pedone, C.; Isernia, C.; Galdiero, M. Analysis of a Membrane Interacting Region af Herpes Simplex Virus Type1 Glycoprotein H. J. Biol. Chem, 2008, 283(44),29993-30009.
122. Galdiero, S.; Falanga, A.; Vitiello, G.; Vitiello, M.; Pedone, C.; D'Errico, G.; Galdiero, M. Role of membranotropic sequences from herpes simplex virus type I glycoproteins B and H in the fusion process. Biochim, Biophys, Acta. 2010, 1798(3), 579-591.
123. Galdiero, S.; Falanga, A.; Vitiello, M.; Browne, H.; Pedone, C.; Galdiero, M. .Fusogenic domains in herpes simplex virus type 1 glycoprotein H. J. Biol. Chem., 2005, 280, 28632-28643. (Pubitemid 41105764)
124. Tu, Y.; Kim, J.S. A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes. J. Gene Med., 2008,10, 646-654. (Pubitemid 351936537)